Misplaced Pages:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox: Difference between revisions

< Misplaced Pages:WikiProject Chemicals | Chembox validation Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 18:07, 16 February 2012 editBeetstra (talk \| contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{drugbox}} taken from revid 472075761 of page 4-Aminosalicylic_acid for the Chem/Drugbox validation project (updated: 'DrugBank').← Previous edit		Revision as of 18:07, 16 February 2012 edit undoBeetstra (talk \| contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{drugbox}} taken from revid 468728871 of page 4-Androstene-3,6,17-trione for the Chem/Drugbox validation project (updated: 'CAS_number').Next edit →
Line 1:		Line 1:
	{{ambox \| text = This page contains a copy of the infobox ({{tl\|drugbox}}) taken from revid of page ] with values updated to verified values.}}		{{ambox \| text = This page contains a copy of the infobox ({{tl\|drugbox}}) taken from revid of page ] with values updated to verified values.}}
	{{Drugbox		{{Drugbox
		⚫	\| verifiedrevid = 447560771
	\| Verifiedfields = changed
			\| IUPAC_name = (10R,13S)-10,13-dimethyl-<br>1,7,8,9,10,11,12,13,15,16-<br>decahydro-2H-cyclopentaphenanthrene-<br>3,6,17(14H)-trione
⚫	\| verifiedrevid = ~~456502374~~
			\| image = 4-Androstene-3,6,17-trione.png
	\| IUPAC_name = 4-amino-2-hydroxy-benzoic acid
	\| image = P-Aminosalicylic acid.svg
	\| width = 180
	\| image2 = 4-Aminosalicylic acid 3d structure vander.png

	<!--Clinical data-->		<!--Clinical data-->
	\| tradename =		\| tradename =
	\| pregnancy_category = C		\| pregnancy_category =
			\| legal_status = unregulated, banned by World Anti-Doping Agency <ref></ref>
	\| legal_UK = POM
	\| routes_of_administration = ~~Oral~~		\| routes_of_administration = oral

	<!--Pharmacokinetic data-->		<!--Pharmacokinetic data-->
	\| bioavailability =		\| bioavailability =
		⚫	\| metabolism =
	\| protein_bound = 50–60%
⚫	\| metabolism = ]
	\| elimination_half-life =		\| elimination_half-life =
	\| excretion = ]		\| excretion =

	<!--Identifiers-->		<!--Identifiers-->
	\| CASNo_Ref = {{cascite\|correct\|CAS}}
	\| CAS_number_Ref = {{cascite\|correct\|??}}		\| CAS_number_Ref = {{cascite\|correct\|??}}
	\| CAS_number = 65-49-6		\| CAS_number = <!-- blanked - oldvalue: 2243-06-3 -->
	\| ~~CAS_supplemental~~ =		\| ATC_prefix =
	\| ~~ATC_prefix~~ = ~~J04~~		\| ATC_suffix =
	\| ~~ATC_suffix~~ = ~~AA01~~		\| PubChem =
		⚫	\| DrugBank_Ref = {{drugbankcite\|correct\|drugbank}}
	\| ATC_supplemental =
	\| ~~PubChem~~ = ~~4649~~		\| DrugBank =
⚫	\| DrugBank_Ref = {{drugbankcite\|~~changed~~\|drugbank}}
	\| DrugBank = DB00233
	\| ChemSpiderID_Ref = {{chemspidercite\|correct\|chemspider}}		\| ChemSpiderID_Ref = {{chemspidercite\|correct\|chemspider}}
	\| ChemSpiderID = ~~4488~~		\| ChemSpiderID = 133080
	\| UNII_Ref = {{fdacite\|correct\|FDA}}
	\| UNII = 5B2658E0N2
	\| KEGG_Ref = {{keggcite\|correct\|kegg}}
	\| KEGG = D00162
	\| ChEBI_Ref = {{ebicite\|correct\|EBI}}
	\| ChEBI = 27565
	\| ChEMBL_Ref = {{ebicite\|correct\|EBI}}
	\| ChEMBL = 1169
	\| NIAID_ChemDB = 020064

	<!--Chemical data-->		<!--Chemical data-->
	\| C=7 \| H=~~7 \| N=1~~ \| O=3		\| C=19 \| H=24 \| O=3
	\| molecular_weight = ~~153~~.~~135 g/mol~~		\| molecular_weight = 300.39
	\| smiles = O=C(O)~~c1ccc~~(~~cc1O~~)N		\| smiles = O=C4\C1=C\C(=O)CC1(3CC2(C(=O)CC23C4)C)C
	\| InChI = 1/~~C7H7NO3~~/c8-4-~~1-2~~-5(7(10)~~11)6~~(9)3-4/h1-3,9H,~~8H2~~,(H,10,~~11)~~		\| InChI = 1/C19H24O3/c1-18-7-5-11(20)9-15(18)16(21)10-12-13-3-4-17(22)19(13,2)8-6-14(12)18/h9,12-14H,3-8,10H2,1-2H3/t12-,13-,14-,18+,19-/m0/s1
	\| InChIKey = ~~WUBBRNOQWQTFEX~~-~~UHFFFAOYAO~~		\| InChIKey = PJMNEPMSGCRSRC-IEVKOWOJBO
	\| StdInChI_Ref = {{stdinchicite\|correct\|chemspider}}		\| StdInChI_Ref = {{stdinchicite\|correct\|chemspider}}
	\| StdInChI = 1S/~~C7H7NO3~~/c8-4-~~1-2~~-5(7(10)~~11)6~~(9)3-4/h1-3,9H,~~8H2~~,(H,10,~~11)~~		\| StdInChI = 1S/C19H24O3/c1-18-7-5-11(20)9-15(18)16(21)10-12-13-3-4-17(22)19(13,2)8-6-14(12)18/h9,12-14H,3-8,10H2,1-2H3/t12-,13-,14-,18+,19-/m0/s1
	\| StdInChIKey_Ref = {{stdinchicite\|correct\|chemspider}}		\| StdInChIKey_Ref = {{stdinchicite\|correct\|chemspider}}
	\| StdInChIKey = ~~WUBBRNOQWQTFEX~~-~~UHFFFAOYSA~~-N		\| StdInChIKey = PJMNEPMSGCRSRC-IEVKOWOJSA-N
	\| melting_point = 150.5
	}}		}}

Revision as of 18:07, 16 February 2012

This page contains a copy of the infobox ({{drugbox}}) taken from revid 468728871 of page 4-Androstene-3,6,17-trione with values updated to verified values.

WikiProject Chemicals/Chembox validation/VerifiedDataSandbox
Clinical data

Routes of administration	oral
Legal status
Legal status	unregulated, banned by World Anti-Doping Agency
Identifiers
IUPAC name (10R,13S)-10,13-dimethyl- 1,7,8,9,10,11,12,13,15,16- decahydro-2H-cyclopentaphenanthrene- 3,6,17(14H)-trione
ChemSpider	133080
Chemical and physical data
Formula	C₁₉H₂₄O₃
Molar mass	300.39 g·mol
3D model (JSmol)	Interactive image
SMILES O=C4\C1=C\C(=O)CC1(3CC2(C(=O)CC23C4)C)C
InChI InChI=1S/C19H24O3/c1-18-7-5-11(20)9-15(18)16(21)10-12-13-3-4-17(22)19(13,2)8-6-14(12)18/h9,12-14H,3-8,10H2,1-2H3/t12-,13-,14-,18+,19-/m0/s1 Key:PJMNEPMSGCRSRC-IEVKOWOJSA-N
(verify)

The World